EYPT

Eyepoint Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth 0/10
  • Momentum 9/10
Eyepoint sales and earnings growth
EYPT Growth
Low
  • Revenue Y/Y -7.38%
  • EPS Y/Y -50.75%
  • FCF Y/Y -80.95%
Eyepoint gross and profit margin trends
EYPT Profitability
Low
  • Gross margin 94.10%
  • EPS margin -486.00%
  • ROIC -87.80%
Eyepoint net debt vs free cash flow
EYPT Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage -14682.5

Eyepoint stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗